UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030206
Receipt No. R000034306
Scientific Title Randomized phase II study of osimertinib plus bevacizumab and osimertinib for chemotherapy-naive patients with nonsquamous non-small cell lung cancer harboring EGFR mutations (investigator-initiated multicenter clinical trial, WJOG9717L)
Date of disclosure of the study information 2017/12/01
Last modified on 2018/10/29 11:22:32

No. Disposal Last modified on Item of update
1 Insert 2017/12/01 09:41:54
2 Update 2017/12/01 09:46:37 Public title
3 Update 2018/06/03 12:33:29 Anticipated trial start date
4 Update 2018/06/04 09:09:29 Recruitment status
5 Update 2018/10/29 11:22:32 Recruitment status


Contact us.